Researchers tracked data from 25,948 adults over the age of 71.

It was important for researchers to confirm these stents didn't increase a patient's long-term risk of adverse events.

Researchers tracked data from the UK Biobank study, sharing their analysis in the Journal of the American College of Cardiology.

The company's latest hire has more than 20 years of leadership experience in the medical device industry. 

Vizient is also working closely with the two companies to boost patient care. 

One researcher described the findings, presented at the Heart Failure Society of America's Annual Scientific Meeting, as "great news for patients and clinicians."

Experts think these new findings could ramp up the development of optimal revascularization strategies.

Delayed PDL was identified in more than 10% of patients undergoing the procedure. 

Pulmonary arterial hypertension (PAH) is a rare, life-threatening disease with no known cure.

CMS finalized the MCIT proposal in January ahead of the White House changeover and had planned to implement it in December.